For the year ending 2025-12-31, ONC made $5,343,033K in revenue. $286,933K in net income. Net profit margin of 5.37%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenues | 5,343,033 | |||
| Cost of sales - product-Product | 668,540 | |||
| Gross profit | 4,674,493 | |||
| Research and development | 2,145,868 | |||
| Selling, general and administrative | 2,081,489 | |||
| Total operating expenses | 4,227,357 | |||
| Income (loss) from operations | 447,136 | |||
| Interest income | 70,505 | |||
| Interest expense | 58,234 | |||
| Other (expense) income, net | -42,553 | |||
| Income (loss) before income taxes | 416,854 | |||
| Income tax expense | 129,921 | |||
| Net income (loss) | 286,933 | |||
| Basic EPS | 0.2 | |||
| Diluted EPS | 0.19 | |||
| Basic Average Shares | 1,417,803,727 | |||
| Diluted Average Shares | 1,474,829,908 | |||
BeOne Medicines Ltd. (ONC)
BeOne Medicines Ltd. (ONC)